Vagus nerve stimulators are those devices that are utilized to stimulate the vagus nerve with electrical impulses. It is used to treat epilepsy and depression. In vagus nerve stimulation, the stimulator is surgically implanted under the skin on the chest, and the device is connected to the left vagus nerve through a wire under the skin. When activated, the device sends the electrical signal to the certain areas of the brain along with the left vagus nerve to the brainstem. With the technological advancement, non-invasive vagus nerve stimulation devices are introduced by the companies which then receive approval by the FDA and CE marks for commercialization and marketing. The market is expected to grow in the near future during the forecast period. Whereas, North America and Europe are expected to be the major regions generating revenue for the market.
The incidence and prevalence rate of epilepsy is rising significantly across the globe. As per the Epilepsy Foundation, one in 26 people develops epilepsy at some point in their lifetime. As per the Institute for Health Metrics and Evaluation the prevalence of epilepsy has reached to more than 27.3 million in 2017 from about 25.3 million in 2013.
No significant US FDA approval for the Vagus Nerve Stimulator has been recorded in 2019. In October 2018, Electrocore has received the US FDA approval for its non-invasive vagus nerve stimulator therapy device to prevent cluster headache as well. It is a self-administered therapy using the GammaCore device. To use the device, the patient had to apply a conductive gel on the side of the neck and then given a mild electrical stimulation through the skin. In October 2017, the US FDA Approved Vagus Nerve Stimulation Therapy system which has an implantable generator (SenTivaTM) and the Therapy Programming System for the treatment of epilepsy.
Research Methodology
The market study of the Vagus Nerve Stimulators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Vagus Nerve Stimulators Market Research and Analysis by Product
2. Vagus Nerve Stimulators Market Research and Analysis by Applications
3. Vagus Nerve Stimulators Market Research and Analysis by End-users
The Report Covers
The incidence and prevalence rate of epilepsy is rising significantly across the globe. As per the Epilepsy Foundation, one in 26 people develops epilepsy at some point in their lifetime. As per the Institute for Health Metrics and Evaluation the prevalence of epilepsy has reached to more than 27.3 million in 2017 from about 25.3 million in 2013.
No significant US FDA approval for the Vagus Nerve Stimulator has been recorded in 2019. In October 2018, Electrocore has received the US FDA approval for its non-invasive vagus nerve stimulator therapy device to prevent cluster headache as well. It is a self-administered therapy using the GammaCore device. To use the device, the patient had to apply a conductive gel on the side of the neck and then given a mild electrical stimulation through the skin. In October 2017, the US FDA Approved Vagus Nerve Stimulation Therapy system which has an implantable generator (SenTivaTM) and the Therapy Programming System for the treatment of epilepsy.
Research Methodology
The market study of the Vagus Nerve Stimulators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Vagus Nerve Stimulators Market Research and Analysis by Product
2. Vagus Nerve Stimulators Market Research and Analysis by Applications
3. Vagus Nerve Stimulators Market Research and Analysis by End-users
The Report Covers
- Comprehensive research methodology of the Vagus Nerve Stimulators market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Vagus Nerve Stimulators market.
- Insights about market determinants which are stimulating the Vagus Nerve Stimulators market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Aleva Neurotherapeutics SA
- BioControl Medical
- Bioness Inc.
- Boston Scientific Corp.
- ElectroCore LLC
- EnteroMedics Inc.
- LivaNova Plc.
- Medtronic Plc
- NeuroPace Inc.
- Nevro Corp.
